Looking Ahead

By Azeem Latib, MD

Perspectives in TAVR

By Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC, and Samir Kapadia, MD, FACC, FSCAI

TAVR in Patients With Aortic Stenosis and Low Surgical Risk

Evaluating new clinical trial data to better understand the benefits and limitations of TAVR in patients at low surgical risk.

By Lars Søndergaard, MD, DMSc, and Nicolo Piazza, MD, PhD

Roundtable Discussion: TAVR in Low-Risk Patients

Experts discuss the significance of recent data and the potential impact on their practice.

With Kentaro Hayashida, MD, PhD, FESC, FACC, FJCS; Robert Ostfeld, MD, MSc, FACC; Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC; Michael J. Reardon, MD; and Steven J. Yakubov, MD, FACC, FSCAI

TAVR Durability: What We Know and When Will We Know What We Don't?

A discussion of what defines durability, an overview of the surgical and transcatheter experience to date, and future directions.

By Faisal Khan, MBBS, and Stephan Windecker, MD

TAVR: General Anesthesia or Moderate Conscious Sedation?

A report of findings from registries and large cohorts.

By Hasan Rehman, MD; Neal S. Kleiman, MD, FACC, MSCAI; and Ankur Kalra, MD, FACP, FACC, FSCAI

TAVI in Bicuspid Aortic Valves

An overview of the current data and technical considerations for transcatheter intervention in bicuspid aortic valves.

By Didier Tchétché, MD

TAVI: Which Valve for Which Patient?

A review of the technical challenges and optimal valve choices in different clinical and anatomic scenarios.

By Noman Ali, PhD, and Daniel J. Blackman, MD

Permanent Pacemaker Implantation After TAVR

Reviewing the current landscape of permanent pacemaker implantation post-TAVR and a look at the road ahead.

By Rahul Sharma, MD, and Rahul P. Sharma, MD

Bioprosthetic Valve Fracture During ViV TAVR

A step-by-step practical guide for performing BVF to facilitate ViV TAVR.

By Ahmed Almomani, MD, and Adnan K. Chhatriwalla, MD

The Evolution of the Structural Heart Program

MedAxiom survey results indicate emerging trends in leadership, staffing, and economics of structural heart programs.

By Ginger Biesbrock, PA-C, MPH, MPAS, AACC

Innovations

An Interview With Gry Dahle, MD

Dr. Dahle shares her thoughts on the current and emerging technologies for valvular disease, as well as her advice for new surgeons entering the field.